Drugs / GSK149203A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01357915 | Jun 2011 → Sep 2012 | cytomegalovirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GSK149203A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01357915 ↗ |
| Modality | Vaccine | “GSK Biologicals' Recombinant CMV glycoprotein B Vaccine” NCT01357915 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT01357915 ↗ |